[1] |
Woo P. Systemic juvenile idiopathic arthritis: diagnosis, management, and outcome[J]. Nat Clin Pract Rheumatol, 2006, 2(1): 28-34.
pmid: 16932649
|
[2] |
Petty RE, Southwood TR, Manners P, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis:second revision, Edmonton, 2001[J]. J Rheumatol, 2004, 31(2): 390-392.
pmid: 14760812
|
[3] |
Gurion R, Lehman TJ, Moorthy LN. Systemic arthritis in children: a review of clinical presentation and treatment[J]. Int J Inflam, 2012, 2012: 271569.
|
[4] |
Lomater C, Gerloni V, Gattinara M, et al. Systemic onset juvenile idiopathic arthritis: a retrospective study of 80 consecutive patients followed for 10 years[J]. J Rheumatol, 2000, 27(2): 491-496.
pmid: 10685819
|
[5] |
Lang BA, Schneider R, Reilly BJ, et al. Radiologic features of systemic onset juvenile rheumatoid arthritis[J]. J Rheumatol, 1995, 22(1): 168-173.
pmid: 7699666
|
[6] |
Schulert GS, Yasin S, Carey B, et al. Systemic juvenile idiopathic arthritis-associated lung disease: characterization and risk factors[J]. Arthritis Rheumatol, 2019, 71(11): 1943-1954.
doi: 10.1002/art.41073
|
[7] |
中国医师协会儿科医师分会风湿免疫学组, 中国儿童免疫与健康联盟, 中国实用儿科杂志编辑委员会. 儿童风湿性疾病相关巨噬细胞活化综合征诊断与治疗专家共识之一——总论篇[J]. 中国实用儿科杂志, 2020, 35(11): 825-831.
|
[8] |
Kimura Y, Weiss JE, Haroldson KL, et al. Childhood Arthritis Rheumatology Research Alliance Carra Net Investigators. Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis[J]. Arthritis Care Res (Hoboken), 2013, 65(5): 745-752.
doi: 10.1002/acr.21889
pmid: 23139240
|
[9] |
Russo RA, Katsicas MM. Patients with very early-onset systemic juvenile idiopathic arthritis exhibit more inflammatory features and a worse outcome[J]. J Rheumatol, 2013, 40(3): 329-334.
doi: 10.3899/jrheum.120386
pmid: 23322471
|
[10] |
Iriguchi S, Kikuchi N, Kaneko S, et al. T-cell-restricted T-bet overexpression induces aberrant hematopoiesis of myeloid cells and impairs function of macrophages in the lung[J]. Blood, 2015, 125(2): 370-382.
doi: 10.1182/blood-2014-05-575225
pmid: 25349175
|
[11] |
Ter Haar NM, Swart JF, et al. Treatment to target using recombinant interleukin-1 receptor antagonist as first-line monotherapy in new-onset systemic juvenile idiopathic arthritis: results from a five-year follow-up study[J]. Arthritis Rheumatol, 2019, 71(7): 1163-1173.
doi: 10.1002/art.40865
|
[12] |
Saper VE, Chen G, Deutsch GH, et al. Childhood Arthritis and Rheumatology Research Alliance Registry Investigators. Emergent high fatality lung disease in systemic juvenile arthritis[J]. Ann Rheum Dis, 2019, 78(12): 1722-1731.
doi: 10.1136/annrheumdis-2019-216040
pmid: 31562126
|
[13] |
Nigrovic PA. Storm warning: lung disease in systemic juvenile idiopathic arthritis[J]. Arthritis Rheumatol, 2019, 71(11): 1773-1775.
doi: 10.1002/art.41071
|